Literature DB >> 29222380

9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2018        PMID: 29222380     DOI: 10.2337/dc18-S009

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  151 in total

Review 1.  The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus.

Authors:  Shazia Hussain; Tahseen A Chowdhury
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

Review 2.  SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials.

Authors:  Xiaoming Jia; Paras B Mehta; Yumei Ye; Mahboob Alam; Yochai Birnbaum; Mandeep Bajaj
Journal:  Curr Diab Rep       Date:  2018-07-11       Impact factor: 4.810

3.  Update on peripheral artery disease: Epidemiology and evidence-based facts.

Authors:  Jun Shu; Gaetano Santulli
Journal:  Atherosclerosis       Date:  2018-05-22       Impact factor: 5.162

4.  Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes.

Authors:  Anjali Gopalan; Pranita Mishra; Stacey E Alexeeff; Maruta A Blatchins; Eileen Kim; Alan Man; Andrew J Karter; Richard W Grant
Journal:  Diabetes Care       Date:  2020-03-04       Impact factor: 19.112

5.  Mediation analysis for estimating cardioprotection of longitudinal RAS inhibition beyond lowering blood pressure and albuminuria in type 1 diabetes.

Authors:  Jingchuan Guo; Ashley I Naimi; Maria M Brooks; Matthew F Muldoon; Trevor J Orchard; Tina Costacou
Journal:  Ann Epidemiol       Date:  2019-12-06       Impact factor: 3.797

6.  Diabetes and Platelet Response to Low-Dose Aspirin.

Authors:  Mohammed E Al-Sofiani; Lisa R Yanek; Nauder Faraday; Brian G Kral; Rasika Mathias; Lewis C Becker; Diane M Becker; Dhananjay Vaidya; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

7.  Diabetes Distress, Depressive Symptoms, and Cardiovascular Health in Adults With Type 1 Diabetes.

Authors:  Margaret M McCarthy; Robin Whittemore; Georica Gholson; Margaret Grey
Journal:  Nurs Res       Date:  2019 Nov/Dec       Impact factor: 2.381

8.  Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registry.

Authors:  Sarah K Lyons; Claire T Boyle; Daniel J DeSalvo; Michael R Rickels; Lauren K Wood Heickman; Kellee M Miller; Nicole C Foster; Mark A Clements
Journal:  Diabetes Obes Metab       Date:  2018-08-16       Impact factor: 6.577

9.  Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness.

Authors:  Sangmo Hong; Munsuk Nam; Bertis B Little; Seihyun Paik; Kwanwoo Lee; Jungtaek Woo; Dooman Kim; Jungoo Kang; Minyoung Chun; Yongsoo Park
Journal:  Heart Vessels       Date:  2019-05-06       Impact factor: 2.037

10.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.